Position in EXEL
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$585,506
+$379,479 QoQ
Shares Held
10,761
+73.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#405
of 751 holders
Holding Since
Dec 2024
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Machina Capital S.A.S. holds $13,316,412 across 9 Biotechnology names. EXEL ranks #8 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,966 | $4,453,681 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,827 | $2,386,287 | |
| 3 | RPRX |
Royalty Pharma plc
|
30,050 | $1,684,903 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
7,540 | $1,412,091 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
29,460 | $1,042,589 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
54,875 | $799,528 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,335 | $702,905 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
10,761 | $585,506 |
All Filings in EXEL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $585,506 | 10,761 | Shares | Sole | 2026-08-10 | |
| 2024-12-31 | $206,027 | 6,187 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||